DR5 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemDR5 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-40237-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene NameTNF receptor superfamily member 10b
NCBI Gene AliasesCD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(2) NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expressionBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieSeptember 1, 2022Hou YJ, Li D, Wang W, Mao L, Fu X, Sun B, Fan C.

(3) AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer CellsCancersJune 21, 2022Jeong S, Farag AK, Yun HK, Jeong YA, Kim DY, Jo MJ, Park SH, Kim BR, Kim JL, Kim BG, et al.

(6) CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cellsJournal of cell communication and signalingDecember 1, 2020Li ZJ, Hou YJ, Hao GP, Pan XX, Fei HR, Wang FZ.

(7) TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptoticOncotargetOctober 20, 2020Ralff MD, Jhaveri A, Ray JE, Zhou L, Lev A, Campbell KS, Dicker DT, Ross EA, El-Deiry WS.

(8) Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific AntibodyCellsOctober 2, 2020Martini S, Figini M, Croce A, Frigerio B, Pennati M, Gianni AM, De Marco C, Daidone MG, Argueta C, Landesman Y, et al.

(9) The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral CarcinomaFrontiers in oncologyJanuary 1, 2020Yeh LY, Yang CC, Wu HL, Kao SY, Liu CJ, Chen YF, Lin SC, Chang KW.

(11) Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5Phytomedicine : international journal of phytotherapy and phytopharmacologySeptember 1, 2019Fei HR, Yuan C, Wang GL, Zhao Y, Li ZJ, Du X, Wang FZ.

(12) Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal CancerCancersMay 9, 2019Kim JL, Kim BR, Kim DY, Jeong YA, Jeong S, Na YJ, Park SH, Yun HK, Jo MJ, Kim BG, et al.

(13) RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancerOncogeneMay 1, 2019Kim BR, Park SH, Jeong YA, Na YJ, Kim JL, Jo MJ, Jeong S, Yun HK, Oh SC, Lee DH.

(15) Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of sclerodermaNature communicationsMarch 8, 2019Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J, et al.

(16) Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5Journal of cellular biochemistryJanuary 1, 2019Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.

(18) Gallic Acid Induces Apoptosis in Human Gastric Adenocarcinoma CellsAnticancer researchApril 1, 2018Tsai CL, Chiu YM, Ho TY, Hsieh CT, Shieh DC, Lee YJ, Tsay GJ, Wu YY.

DR5 shRNA Plasmid (h)